T Rowe PR Health Science-InvPRHSX
13F holders, Q4 2024 (December 31)5holders
0new positions
0sold out
$79.54avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Ethos Financial Group, LLC ($203K), Westside Investment Management, Inc. ($117K) and Coston, McIsaac & Partners ($76K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 123 shares bought and 36 shares sold, net +87 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Ethos Financial Group, LLC | 0.03% | Reduce -1.4% | 2,555 | $203K |
| Westside Investment Management, Inc. | 0.02% | No change | 1,467 | $117K |
| Coston, McIsaac & Partners | 0.02% | Add +12.6% | 956 | $76K |
| Financial Gravity Companies, Inc. | 0.00% | Add +13.1% | 112 | $9K |
| Tucker Asset Management LLC | 0.00% | Add +11.1% | 30 | $2K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.